Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Exelixis (EXEL)

NASDAQ:EXEL

US Market

EXEL

Exelixis

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Exelixis (EXEL) Stock News & Sentiment

3,064 Followers

Exelixis’s Promising Study on XB371: A New Hope for Solid Tumors

Company Announcements

Exelixis’s Promising Study on XB371: A New Hope for Solid Tumors

9h ago

Exelixis and Novartis: Key Updates from the Pan Tumor Rollover Study

Company Announcements

Exelixis and Novartis: Key Updates from the Pan Tumor Rollover Study

1d ago

Exelixis’s Promising Study on Renal Cell Carcinoma: A Potential Game Changer?

Company Announcements

Exelixis’s Promising Study on Renal Cell Carcinoma: A Potential Game Changer?

4d ago

Exelixis’s Innovative RCC Study: A Potential Game-Changer?

Company Announcements

Exelixis’s Innovative RCC Study: A Potential Game-Changer?

8d ago

Exelixis’s Promising Study on Renal Cell Carcinoma: Key Updates for Investors

Company Announcements

Exelixis’s Promising Study on Renal Cell Carcinoma: Key Updates for Investors

9d ago

Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment

Company Announcements

Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment

13d ago

Exelixis and Merck’s Promising Study on Renal Cell Carcinoma Treatment

Company Announcements

Exelixis and Merck’s Promising Study on Renal Cell Carcinoma Treatment

27d ago

More EXEL News >

EXEL News on the Web

2025-08-28

Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?

Zacks

Neutral

2025-08-27

Why Is Exelixis (EXEL) Up 3.8% Since Last Earnings Report?

Zacks

Neutral

2025-08-26

Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?

Zacks

Neutral

2025-08-25

Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?

Zacks

Neutral

2025-08-19

Will EXEL's Share Repurchase Program Boost Value for Investors?

Zacks

Neutral

2025-08-18

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

Neutral

2025-08-14

Exelixis Gains 15.6% YTD: How Should You Play the Stock?

Zacks

Bullish

2025-08-13

Will Zanzalintinib Ease Out EXEL's Reliance on Cabometyx for Growth?

Zacks

Neutral

News Score - Last 7 Days

Neutral

EXEL

Sector Average

Media Buzz

This Week5 articles

Weekly Average2.75 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EXEL’s Media Buzz Sentiment?

5 articles about EXEL were published this week. In an average week, 2.75 articles are published.

What is EXEL’s weekly average amount of articles?

In an average week, 2.75 articles about EXEL are published.

What is EXEL’s News Sentiment?

50% of articles about EXEL were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

COOCooper Co

PAHCPhibro Animal Health

ANSLFAnsell

WBAWalgreens Boots Alliance

ANIPANI Pharmaceuticals

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing